Catalyst Bioscience News Today

Apexigen (NASDAQ:APGN – Get Rating) and Catalyst Biosciences (NASDAQ:CBIO – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership. Volatility and Risk Apexigen has a beta of 3.94, suggesting […]

SAN DIEGO and TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage...

Analysts predict that Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) will announce ($0.43) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have made estimates for Catalyst Biosciences’ earnings, with estimates ranging from ($0.64) to ($0.22). Catalyst Biosciences posted earnings per share of ($0.64) in the same quarter last year, which would […]

Equities research analysts expect Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) to announce earnings of ($0.44) per share for the current quarter, according to Zacks. Zero analysts have made estimates for Catalyst Biosciences’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.31). Catalyst Biosciences posted earnings per share of ($0.64) during the […]

Equities research analysts forecast that Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) will announce ($0.56) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Catalyst Biosciences’ earnings. The lowest EPS estimate is ($0.79) and the highest is ($0.40). Catalyst Biosciences reported earnings per share of […]